Skip to main content

Becton, Dickinson and Company

corporate_fare Company Profile

Becton, Dickinson and Company

BDX·NYSE·Industrial Applications And Services·CIK 0000010795

Becton, Dickinson and Company (BD) is a global medical technology company that develops, manufactures, and sells a wide range of medical supplies, devices, laboratory equipment, and diagnostic products. These products are used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. BD's solutions aim to improve medication management and patient safety, support infection prevention, equip surgical and interventional procedures, improve drug delivery, aid anesthesiology care, enhance the diagnosis of infectious diseases and cancers, and advance cellular research and applications. As of September 30, 2025, BD operated through three worldwide business segments: BD Medical, BD Life Sciences, and BD Interventional. Effective October 1, 2025, BD reorganized into five distinct, separately-managed segments: Medical Essentials, Connected Care, BioPharma Systems, Interventional, and Life Sciences. The Life Sciences segment will remain a critical part of BD until the separation and combination of its Biosciences and Diagnostic Solutions business with Waters Corporation is completed. BD Medical produces a broad array of medical technologies and devices used to improve healthcare delivery in various settings. BD was incorporated in New Jersey in November 1906, succeeding a New York business started in 1897.

Becton, Dickinson and Company (NYSE:BDX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 33 items for BDX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for BDX spans 8-K, 10-Q, FWP.

Recent high-impact activity:

  • BD Q4 Profit Jumps to $696M as Revenue Rises 5.4% to $5.27B
  • BD Posts Q4 Revenue of $5.3B, Guides FY27 Adjusted EPS to $13.10-$13.30
  • BD Guides FY Adjusted EPS to $13.10-$13.30
  • BD CEO Details $1B Nebraska Expansion, Plans to Make All U.S. Needles Domestically
  • BD's Agility Trial Hits Positive Results, Bolstering Peripheral Vascular Portfolio

Financial Snapshot

Fiscal year ended September 30, 2025
Revenue
$21.84B
Net Income
$1.68B
Diluted EPS
$5.82
Gross Profit
$9.93B
Operating Income
$2.58B
Cash & Equivalents
$641M
Total Debt
$19.18B
Debt / Equity
0.76×
Net Margin
7.7%
Shares Outstanding
287.65M sh
Source: 10-K · filed 2025-11-25 · accession 0000010795-25-000099

Short Interest & Short Volume

5.20 days to cover

FINRA reported short interest of 8,105,536 shares in BDX as of the October 30, 2026 settlement, a 9.0% decrease from the prior period — about 5.2 days to cover at its recent average daily volume. On November 20, 2026, 40.7% of BDX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)8,105,536 shares as of October 30, 2026
Change vs prior period▼ 9.0%
Days to cover5.20 at avg daily volume of 1,557,358
Daily short volume (FINRA facilities)40.7% of 750,968 shares on November 20, 2026
5-day average short volume52.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with B →
$212.78
52-week range · as of 2026-11-05 $127.54 – $212.78
Market cap
$57.96B
Volume
2M (1.0× avg)
3-mo avg 1.9M
Live data · 2026-11-21 11:02 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BDX - Latest Insights

BDX
Nov 05, 2026, 6:54 AM EST
Source: dpa-AFX
Importance Score:
7
Price at Filing: $206.00
Real-time Price: $212.78 info
Change: +$6.78 (+3%) info
Market Cap: $57.958B info
BDX
Nov 05, 2026, 6:31 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $204.07
Real-time Price: $212.78 info
Change: +$8.71 (+4%) info
Market Cap: $57.958B info
BDX
Nov 05, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $205.50
Real-time Price: $212.78 info
Change: +$7.28 (+4%) info
Market Cap: $57.958B info
BDX
Oct 07, 2026, 1:00 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $181.41
Real-time Price: $212.78 info
Change: +$31.38 (+17%) info
Market Cap: $57.958B info
BDX
Oct 07, 2026, 8:20 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $177.43
Real-time Price: $212.78 info
Change: +$35.35 (+20%) info
Market Cap: $57.958B info
BDX
Oct 06, 2026, 7:15 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Updated Oct 6, 1:32 PM ET — BD shares rose 2.06% to $184.38 following the announcement.
Price at Filing: $182.00
Real-time Price: $212.78 info
Change: +$30.78 (+17%) info
Market Cap: $57.958B info
BDX
Oct 05, 2026, 11:20 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $180.60
Real-time Price: $212.78 info
Change: +$32.18 (+18%) info
Market Cap: $57.958B info
BDX
Aug 06, 2026, 4:36 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $177.07
Real-time Price: $212.78 info
Change: +$35.71 (+20%) info
Market Cap: $57.958B info
BDX
Aug 06, 2026, 6:51 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $172.00
Real-time Price: $212.78 info
Change: +$40.78 (+24%) info
Market Cap: $57.958B info
BDX
Aug 06, 2026, 6:31 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $172.00
Real-time Price: $212.78 info
Change: +$40.78 (+24%) info
Market Cap: $57.958B info
BDX
Jul 31, 2026, 2:37 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $165.42
Real-time Price: $212.78 info
Change: +$47.37 (+29%) info
Market Cap: $57.958B info
BDX
Jul 29, 2026, 6:54 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $161.25
Real-time Price: $212.78 info
Change: +$51.53 (+32%) info
Market Cap: $57.958B info
BDX
Jun 23, 2026, 6:50 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $140.78
Real-time Price: $212.78 info
Change: +$72.00 (+51%) info
Market Cap: $57.958B info
BDX
May 29, 2026, 8:39 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $148.41
Real-time Price: $212.78 info
Change: +$64.37 (+43%) info
Market Cap: $57.958B info
BDX
May 20, 2026, 5:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $146.95
Real-time Price: $212.78 info
Change: +$65.83 (+45%) info
Market Cap: $57.958B info
BDX
May 12, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $147.51
Real-time Price: $212.78 info
Change: +$65.27 (+44%) info
Market Cap: $57.958B info
BDX
May 11, 2026, 6:21 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $143.15
Real-time Price: $212.78 info
Change: +$69.63 (+49%) info
Market Cap: $57.958B info
BDX
May 11, 2026, 4:26 PM EDT
Filing Type: FWP
Importance Score:
7
Price at Filing: $143.20
Real-time Price: $212.78 info
Change: +$69.58 (+49%) info
Market Cap: $57.958B info
BDX
May 11, 2026, 8:40 AM EDT
Source: MFN by Modular Finance
Importance Score:
7
Price at Filing: $150.00
Real-time Price: $212.78 info
Change: +$62.78 (+42%) info
Market Cap: $57.958B info
BDX
May 07, 2026, 5:25 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $153.26
Real-time Price: $212.78 info
Change: +$59.52 (+39%) info
Market Cap: $57.958B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets